Skip to main content
OpenTrials
Completed

NCT Number: NCT06712901

Social Media and Cancer Screening Information

NORC/AmeriSpeak will recruit participants who meet the study criteria and invite them to complete a 15-minute survey. Participants will be randomly assigned to one of five conditions, with approximately 400 people in each condition, and will respond to various questions after viewing the study messaging. Once 2,000 participants complete the survey, the data will be de-identified and provided to the study team for analysis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Colorectal Cancer Colonic Diseases Colorectal Neoplasms Digestive System Diseases Digestive System Neoplasms Gastrointestinal Diseases Gastrointestinal Neoplasms Intestinal Diseases Intestinal Neoplasms Neoplasms Neoplasms by Site Rectal Diseases

Age range

45 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Andy King

Salt Lake City, Utah, 84112, United States

About this study

NORC/AmeriSpeak will put all of the study content into their system. They will send out the opportunity to participate in the study, which should take about 15 minutes, to people in their panel who meet our participation criteria. Participants will be directed to the study information sheet that includes all elements of consent. Participants who agree to participate will start the survey experiment. The survey experiment will randomize participants into one of five conditions: (1) control (no exposure), (2) overall median ranked messages (from the prior study), (3) messages preferred by all participants, (4) messages preferred by Black American participants, and (5) messages preferred by White American participants. Approximately 400 people will complete each condition. After viewing the study stimuli (or no stimuli in the control condition), participants will respond to various outcomes and other variables of interest (see questionnaire draft included). After all 2,000 people have completed the study, the study team will receive a de-identified data file from NORC/AmeriSpeak with all study data and engage in analysis. This study is planned to close the study around that time as the study team completes data analysis and write-up the findings.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Identify as white/Caucasian or Black/African American.

Exclusion criteria

  • Do not identify as white/Caucasian or Black/African American.
  • Previously diagnosed with colorectal cancer
  • Non-English speakers

Treatment and study plan

Median Ranked Cancer Screening Messaging

Behavioral

Strong message content that increases screening and sharing intentions. Messages in this intervention were median ranked in the prior study.

Overall Preferred Cancer Screening Messaging

Behavioral

Strong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by all participants in the prior study.

Black American Preferred Cancer Screening Messaging

Behavioral

Strong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by Black participants but not White participants in the prior study.

White American Preferred Cancer Screening Messaging

Behavioral

Strong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by White participants but not Black participants.

Control

Behavioral

There will be no message content of cancer screening and sharing intentions in this arm.

Primary outcomes

  1. Intentions to Adhere to Colorectal Cancer Screening (CRCS) Recommendations

    Time frame: 15 minutes

    After reading cancer screening (CRCS) recommendations, this outcome will assess how likely they are to follow on the the screening recommendations.

    Response options: Very unlikely (1), unlikely, neither unlikely nor likely, likely, very likely (5)

    A higher score indicates a favorable outcome, and a lower score indicates a less favorable outcome.

  2. Intentions to Adhere Test Preference Indication

    Time frame: 15 minutes

    To determine which colorectal cancer screening (CRCS) participants are most likely to choose.

    Response options: stool-based tests (e.g., FOBT or FIT); endoscopic/scoping approach (e.g., colonoscopy or sigmoidoscopy); whatever my doctor recommends to me; something other than a stool-based or scoping approach; I would not follow the recommendations.

    This outcome will report the count of responses.

Secondary outcomes

  1. Likelihood of Sharing Information Via Social Media

    Time frame: 15 minutes

    This outcome measure will determine how likely participants are to share the messages about colon cancer screening on social media.

    Response options: Very unlikely (1), unlikely, neither unlikely nor likely, likely, very likely (5)

    A higher score indicates a favorable outcome, and a lower score indicates a less favorable outcome.

  2. Information Sharing Behavior

    Time frame: 15 minutes

    This outcome will report the count of participants will seek more information after the study.

    The participants will be asked a question on if they would like more information (Yes/No) and survey vendor will track participants who click a link to an external resource like the American Cancer Society to learn more.

Sponsors and collaborators

Lead sponsor

University of Utah

Other

Collaborators

  • AmeriSpeak - NORC
  • National Cancer Institute (NCI)

Registry information

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Dec 2, 2024
Registry last updated
Mar 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.